GR3025951T3 - Alpha amino acid derivatives, a method for their preparation and pharmaceutical preparations containing them. - Google Patents
Alpha amino acid derivatives, a method for their preparation and pharmaceutical preparations containing them.Info
- Publication number
- GR3025951T3 GR3025951T3 GR980400121T GR980400121T GR3025951T3 GR 3025951 T3 GR3025951 T3 GR 3025951T3 GR 980400121 T GR980400121 T GR 980400121T GR 980400121 T GR980400121 T GR 980400121T GR 3025951 T3 GR3025951 T3 GR 3025951T3
- Authority
- GR
- Greece
- Prior art keywords
- preparation
- amino acid
- acid derivatives
- pharmaceutical preparations
- preparations containing
- Prior art date
Links
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Peptides Or Proteins (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9307928A FR2707085B1 (fr) | 1993-06-30 | 1993-06-30 | Nouveaux dérivés d'alpha amino acides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3025951T3 true GR3025951T3 (en) | 1998-04-30 |
Family
ID=9448691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR980400121T GR3025951T3 (en) | 1993-06-30 | 1998-01-20 | Alpha amino acid derivatives, a method for their preparation and pharmaceutical preparations containing them. |
Country Status (13)
Country | Link |
---|---|
US (2) | US5470864A (el) |
EP (1) | EP0632026B1 (el) |
JP (1) | JP2688175B2 (el) |
AT (1) | ATE160338T1 (el) |
AU (1) | AU673739B2 (el) |
CA (1) | CA2127066A1 (el) |
DE (1) | DE69406853T2 (el) |
DK (1) | DK0632026T3 (el) |
ES (1) | ES2111871T3 (el) |
FR (1) | FR2707085B1 (el) |
GR (1) | GR3025951T3 (el) |
NZ (1) | NZ260874A (el) |
ZA (1) | ZA944728B (el) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0111872D0 (en) | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
US7727964B2 (en) * | 2001-11-26 | 2010-06-01 | Trustees Of Tufts College | Peptidomimetic inhibitors of post-proline cleaving enzymes |
FR2833494B1 (fr) * | 2001-12-19 | 2006-12-15 | Univ Nantes | Utilisation de composes de la famille des benzamides comme agent immunosuppresseur |
US7968605B2 (en) | 2002-02-04 | 2011-06-28 | ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
EP2319518A1 (en) | 2002-02-04 | 2011-05-11 | ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. | Use of CO-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases |
CA2534415A1 (en) * | 2003-08-04 | 2005-02-17 | Northwick Park Institute For Medical Research | Therapeutic delivery of carbon monoxide |
US7576206B2 (en) | 2003-08-14 | 2009-08-18 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
US7223745B2 (en) | 2003-08-14 | 2007-05-29 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
US7468383B2 (en) | 2005-02-11 | 2008-12-23 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
GB0601394D0 (en) | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
EP2516449A1 (en) | 2009-12-22 | 2012-10-31 | Cephalon, Inc. | Proteasome inhibitors and processes for their preparation, purification and use |
ES2656237T3 (es) | 2011-04-19 | 2018-02-26 | Alfama, Inc. | Moléculas liberadoras de monóxido de carbono y usos de las mismas |
WO2013013179A1 (en) | 2011-07-21 | 2013-01-24 | Alfama, Inc. | Ruthenium carbon monoxide releasing molecules and uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1297633C (en) * | 1985-09-27 | 1992-03-17 | Shosuke Okamoto | Phenylalanine derivative and proteinase inhibitor |
-
1993
- 1993-06-30 FR FR9307928A patent/FR2707085B1/fr not_active Expired - Fee Related
-
1994
- 1994-06-08 EP EP94401267A patent/EP0632026B1/fr not_active Expired - Lifetime
- 1994-06-08 DE DE69406853T patent/DE69406853T2/de not_active Expired - Fee Related
- 1994-06-08 DK DK94401267T patent/DK0632026T3/da active
- 1994-06-08 AT AT94401267T patent/ATE160338T1/de not_active IP Right Cessation
- 1994-06-08 ES ES94401267T patent/ES2111871T3/es not_active Expired - Lifetime
- 1994-06-28 AU AU66023/94A patent/AU673739B2/en not_active Ceased
- 1994-06-29 JP JP6147688A patent/JP2688175B2/ja not_active Expired - Lifetime
- 1994-06-29 CA CA002127066A patent/CA2127066A1/fr not_active Abandoned
- 1994-06-29 NZ NZ260874A patent/NZ260874A/en unknown
- 1994-06-30 US US08/268,289 patent/US5470864A/en not_active Expired - Fee Related
- 1994-06-30 ZA ZA944728A patent/ZA944728B/xx unknown
-
1995
- 1995-05-09 US US08/437,399 patent/US5585390A/en not_active Expired - Fee Related
-
1998
- 1998-01-20 GR GR980400121T patent/GR3025951T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU673739B2 (en) | 1996-11-21 |
EP0632026B1 (fr) | 1997-11-19 |
FR2707085A1 (fr) | 1995-01-06 |
DE69406853T2 (de) | 1998-06-18 |
ATE160338T1 (de) | 1997-12-15 |
JPH07149727A (ja) | 1995-06-13 |
CA2127066A1 (fr) | 1994-12-31 |
DK0632026T3 (da) | 1998-07-27 |
NZ260874A (en) | 1995-09-26 |
DE69406853D1 (de) | 1998-01-02 |
ZA944728B (en) | 1995-07-13 |
AU6602394A (en) | 1995-01-12 |
FR2707085B1 (fr) | 1995-08-18 |
JP2688175B2 (ja) | 1997-12-08 |
ES2111871T3 (es) | 1998-03-16 |
EP0632026A1 (fr) | 1995-01-04 |
US5585390A (en) | 1996-12-17 |
US5470864A (en) | 1995-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATA256092A (de) | Aminosäurederivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
AU2125192A (en) | New naphthylethlylureas and naphthylethylthioureas, process for the preparation thereof, and pharmaceutical compositions containing them | |
DE69219394D1 (de) | Heterozyklische Alkylamide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen | |
AU673893B2 (en) | New pyridothiadiazones, processes for their preparation and the pharmaceutical compositions which contain them | |
AU656466B2 (en) | New benzimidazole compounds, a process for their preparation and pharmaceutical compositions containing them | |
GR3025951T3 (en) | Alpha amino acid derivatives, a method for their preparation and pharmaceutical preparations containing them. | |
IL109139A0 (en) | Diamine salts of clavulanic acid, their preparation and pharmaceutical compositions containing them | |
HUT68774A (en) | Heterocyclic iminobismethylenebisphosphonic acid derivatives, process for preparing them, and pharmaceutical preparations containing them | |
HUT72319A (en) | Epoxy-succinic acid derivatives, pharmaceutical compositions containing them and process for their preparation | |
ZA932359B (en) | 3-Aminochroman spiro compounds processes for preparing them and pharmaceutical compositions containing them | |
IE873212L (en) | Medicaments based on derivatives of 3,4-di-phenylpiperidine,¹the use of the derivatives as medicaments, and novel¹3,4-diphenylpiperidine derivatives and a process for the¹preparation therefor | |
AU4128793A (en) | New peptide compounds having bradykinin-antagonist activity, process for their preparation and the pharmaceutical compositions which contain them | |
AU5522794A (en) | New angiopeptin cyclopeptide compounds, process for the preparation thereof, and pharmaceutical compositios containing them | |
AU5971990A (en) | Renin-inhibiting amino oligohydroxy derivatives | |
AU672791B2 (en) | N-derivatives of (phenylethyl-beta-ol) amine, a process for their preparation and pharmaceutical compositions containing the same | |
DE69215511T2 (de) | Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen | |
GR3019565T3 (en) | Substituted 3-thia- or 3-oxa-alkyl flavones, process for their preparation, their application and drugs based on these compounds as well as intermediates | |
HU912826D0 (en) | Methods for producing new amino acid derivatives and pharmaceutical preparatives containing said compounds |